CLINICAL_TRIALS
trial_result
· 2020-02-12
Clinical Trial Update: Trametinib With GSK2141795 in BRAF Wild-type Melanoma [Phase 2]
Summary
Phase 2 trial update evaluating trametinib with GSK2141795 in BRAF wild-type melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Adil Daud | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2020-02-12